М. В. Марсова

520 total citations
26 papers, 363 citations indexed

About

М. В. Марсова is a scholar working on Molecular Biology, Neurology and Food Science. According to data from OpenAlex, М. В. Марсова has authored 26 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Neurology and 6 papers in Food Science. Recurrent topics in М. В. Марсова's work include Probiotics and Fermented Foods (5 papers), bioluminescence and chemiluminescence research (4 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). М. В. Марсова is often cited by papers focused on Probiotics and Fermented Foods (5 papers), bioluminescence and chemiluminescence research (4 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). М. В. Марсова collaborates with scholars based in Russia, Tajikistan and Kazakhstan. М. В. Марсова's co-authors include В. Н. Даниленко, Е. У. Полуэктова, О. В. Аверина, Roman А. Yunes, Г. И. Ковалев, Е. В. Васильева, Elena Poluektova, A. V. Revishchin, Rustem Ilyasov and Galina Pavlova and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Antioxidants.

In The Last Decade

М. В. Марсова

22 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
М. В. Марсова Russia 10 222 143 69 61 44 26 363
Subramanian Thangaleela Thailand 13 170 0.8× 95 0.7× 89 1.3× 31 0.5× 46 1.0× 29 427
Guoxia Liu China 11 349 1.6× 62 0.4× 53 0.8× 53 0.9× 23 0.5× 24 457
Núria González Spain 14 337 1.5× 157 1.1× 108 1.6× 30 0.5× 35 0.8× 20 635
Joshua Maher United States 5 274 1.2× 67 0.5× 123 1.8× 74 1.2× 11 0.3× 10 451
Elena Franco‐Robles Mexico 11 149 0.7× 150 1.0× 76 1.1× 30 0.5× 60 1.4× 29 479
Qingmin Kong China 7 305 1.4× 70 0.5× 164 2.4× 45 0.7× 17 0.4× 9 458
Guangsu Zhu China 10 285 1.3× 150 1.0× 183 2.7× 113 1.9× 33 0.8× 16 478
Emily Schifano Italy 14 264 1.2× 163 1.1× 52 0.8× 23 0.4× 23 0.5× 36 512
Berkley Luk United States 4 415 1.9× 133 0.9× 172 2.5× 112 1.8× 48 1.1× 9 610
Atsushi Ishihara Japan 10 539 2.4× 84 0.6× 161 2.3× 163 2.7× 194 4.4× 11 797

Countries citing papers authored by М. В. Марсова

Since Specialization
Citations

This map shows the geographic impact of М. В. Марсова's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by М. В. Марсова with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites М. В. Марсова more than expected).

Fields of papers citing papers by М. В. Марсова

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by М. В. Марсова. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by М. В. Марсова. The network helps show where М. В. Марсова may publish in the future.

Co-authorship network of co-authors of М. В. Марсова

This figure shows the co-authorship network connecting the top 25 collaborators of М. В. Марсова. A scholar is included among the top collaborators of М. В. Марсова based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with М. В. Марсова. М. В. Марсова is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Полуэктова, Е. У., et al.. (2025). Gut Microbiome as a Source of Probiotic Drugs for Parkinson’s Disease. International Journal of Molecular Sciences. 26(19). 9290–9290. 1 indexed citations
2.
Butenko, Ivan, et al.. (2024). Levilactobacillus brevis 47f: Bioadaptation to Low Doses of Xenobiotics in Aquaculture. Biology. 13(11). 925–925.
3.
Марсова, М. В., et al.. (2024). Modern Approaches to Investigating the Effectiveness of Probiotics in Aquaculture. Biology Bulletin Reviews. 14(S3). S376–S404.
4.
Воронков, Д. Н., et al.. (2024). Effects of the pharmabiotic U-21 in a combined neuroinflammatory model of Parkinson's disease in rats. Bulletin of Experimental Biology and Medicine. 177(2). 193–199. 3 indexed citations
5.
Марсова, М. В., et al.. (2024). Effects of the Pharmabiotic U-21 under Conditions of a Combined Neuroinflammatory Model of Parkinson’s Disease in Rats. Bulletin of Experimental Biology and Medicine. 177(2). 225–230. 1 indexed citations
6.
Марсова, М. В., et al.. (2024). Nematode Caenorhabditis elegans as an Object for Testing the Genotoxicity of Chemical Compounds. Russian Journal of Genetics. 60(9). 1148–1152.
7.
Марсова, М. В., et al.. (2023). The Effects of Acute Bisphenol A Toxicity on the Hematological Parameters, Hematopoiesis, and Kidney Histology of Zebrafish (Danio rerio). Animals. 13(23). 3685–3685. 9 indexed citations
8.
Даниленко, В. Н., et al.. (2023). Ability of Lactobacillus brevis 47f to Alleviate the Toxic Effects of Imidacloprid Low Concentration on the Histological Parameters and Cytokine Profile of Zebrafish (Danio rerio). International Journal of Molecular Sciences. 24(15). 12290–12290. 11 indexed citations
9.
10.
Даниленко, В. Н., et al.. (2021). Common Inflammatory Mechanisms in COVID-19 and Parkinson’s Diseases: The Role of Microbiome, Pharmabiotics and Postbiotics in Their Prevention. Dove Medical Press (Taylor and Francis Group). 24 indexed citations
11.
Ушакова, Н. А., et al.. (2021). Novel Extract from Beetle Ulomoides dermestoides: A Study of Composition and Antioxidant Activity. Antioxidants. 10(7). 1055–1055. 13 indexed citations
12.
Аверина, О. В., Е. У. Полуэктова, М. В. Марсова, & В. Н. Даниленко. (2021). Biomarkers and Utility of the Antioxidant Potential of Probiotic Lactobacilli and Bifidobacteria as Representatives of the Human Gut Microbiota. Biomedicines. 9(10). 1340–1340. 84 indexed citations
13.
Ушакова, Н. А., et al.. (2021). Антиоксидантные свойства экстракта личинок Hermetia illucens . Известия Российской академии наук Серия биологическая. 121–125. 1 indexed citations
14.
Даниленко, В. Н., et al.. (2020). The use of a pharmabiotic based on the Lactobacillus fermentum U-21 strain to modulate the neurodegenerative process in an experimental model of Parkinson disease. SHILAP Revista de lepidopterología. 14(1). 7 indexed citations
15.
Марсова, М. В., et al.. (2020). Protective effects of Lactobacillus fermentum U-21 against paraquat-induced oxidative stress in Caenorhabditis elegans and mouse models. World Journal of Microbiology and Biotechnology. 36(7). 104–104. 29 indexed citations
16.
Yunes, Roman А., Е. У. Полуэктова, Е. В. Васильева, et al.. (2019). A Multi-strain Potential Probiotic Formulation of GABA-Producing Lactobacillus plantarum 90sk and Bifidobacterium adolescentis 150 with Antidepressant Effects. Probiotics and Antimicrobial Proteins. 12(3). 973–979. 107 indexed citations
17.
Марсова, М. В., et al.. (2018). A bioluminescent test system reveals valuable antioxidant properties of lactobacillus strains from human microbiota. World Journal of Microbiology and Biotechnology. 34(2). 27–27. 28 indexed citations
18.
Марсова, М. В., et al.. (2018). Lux Biosensors: Screening Biologically Active Compounds for Genotoxicity. Russian Journal of Genetics Applied Research. 8(1). 87–95. 4 indexed citations
19.
20.
Марсова, М. В., et al.. (2016). Lux-biosensors: screening biologically active compounds for genotoxicity. Ecological genetics. 14(4). 52–62. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Subramanian Thangaleela Breakdown of academic impact, for papers by Guoxia Liu Breakdown of academic impact, for papers by Núria González Breakdown of academic impact, for papers by Joshua Maher Breakdown of academic impact, for papers by Elena Franco‐Robles Breakdown of academic impact, for papers by Qingmin Kong Breakdown of academic impact, for papers by Guangsu Zhu Breakdown of academic impact, for papers by Emily Schifano Breakdown of academic impact, for papers by Berkley Luk Breakdown of academic impact, for papers by Atsushi Ishihara
Rankless by CCL
2026